SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending following its Q4 earnings report, where a headline revenue and EPS miss was overshadowed by management's beat on ARR guidance and positive adjusted EBITDA. Despite initial volatility, the stock saw a strong recovery as the community rallies around its reaffirmed 2026 guidance and robust AI infrastructure expansion, sparking discussions of a potential short squeeze.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is trending after reporting a significant earnings beat and strong forward guidance, notably highlighting AI as an increasing tailwind for its business, which has surprised the market and appears to be fueling a short squeeze. The community is actively discussing the company's turnaround, its perceived undervaluation compared to peers, and the potential for a substantial price run.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin (APP) is trending following an earnings report that significantly beat revenue and profit estimates with strong guidance, despite the stock experiencing a notable drop. The community is actively debating if the dip is a buying opportunity, citing the company's robust fundamentals and ongoing share buyback program amid a broader software sector pullback.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as the company announced plans to advance its oral weight-loss drug, VK2735, directly into Phase 3 studies, accelerating its development timeline significantly and fueling community speculation about its "best-in-class" potential. This rapid progression, alongside a strong cash position, has intensified discussions around potential major partnerships or buyouts, while also creating a battleground for shorts betting against its valuation.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is trending following Romania's approval of its SMR project and a new AI-guided fuel management partnership, drawing significant institutional interest including BlackRock's increased stake. While bulls foresee SMRs as a vital solution for future energy demand, especially for AI, and anticipate a short squeeze, the community remains divided on valuation and execution risks amidst ongoing price volatility.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is gaining investor attention with BlackRock recently increasing its stake, as the community eagerly awaits updates on its promising NSCLC trial and progresses towards a prostate cancer BLA, with many speculating on potential Big Pharma partnerships or a buyout driven by the sector's patent cliff and vulnerable short interest.

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

NovoCure Ltd

NovoCure is trending following FDA approval of its Optune Pax device for locally advanced pancreatic cancer, hailed by many as a revolutionary breakthrough for a difficult-to-treat disease, while some community members question the magnitude of the clinical benefit and commercial rollout potential.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco Systems is actively discussed after its latest earnings report, which showcased robust AI infrastructure demand and an improved financial outlook, yet shares declined due to a lower-than-anticipated gross margin forecast impacted by rising memory costs. The community is debating its current valuation and long-term potential in the AI boom, drawing parallels to past market cycles.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management system, as well as other tools, integrations and native payment solutions. It operates through the following geographical segments: Americas, Europe and Asia Pacific. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot announced strong Q4 earnings, raised its forward guidance, and initiated a significant share repurchase program. However, the stock experienced a notable post-earnings decline, sparking an intense community debate over whether robust fundamentals can outweigh persistent market fears about AI disruption in the broader software sector.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is seeing significant conversation driven by the ongoing uncertainty and regulatory scrutiny surrounding its proposed Warner Bros. Discovery acquisition, coupled with an activist investor's push for a rival bid and notable insider selling. This dynamic has polarized the community between those fearing further declines due to deal complications and others viewing it as a generational buying opportunity for the streaming leader.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$VSEE - Expansion with Major Hospitals: Two new hospitals are now live on the iDoc platform, conservatively projected to generate $500,000 in annual revenue. This activation builds on our strong partnership, enhancing critical care delivery and setting the stage for even greater expansion.
https://finance.yahoo.com/news/vsee-healths-idoc-division-powers-131800965.html

SAN JOSE, CALIFORNIA / ACCESS Newswire / November 25, 2025 / VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine solutions, today announced exciting progress in implementing and fulfilling its previously announced contracts through ...

Yahoo Finance

VSee Health's iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth!

StockTwits For Android 

VSee Health Inc.

 - Expansion with Major Hospitals: Two new hospitals are now live on the iDoc platform, conservatively projected to generate $500,000 in annual revenue. This activation builds on our strong partnership, enhancing critical care delivery and setting the stage for even greater expansion.
